Invest In Biomed Program
Invest In Biomed 2025 is launched!
This unique program helps selected startups to structure their fundraising and meet specialized investors in their sector.

Benefits for Invest In Biomed 2025 startups
- Adapt their communications to convince investors
- Get personalized feedback on the content and form of their pitch deck from experienced healthcare fundraising professionals
- Receive coaching on their oral performance
- Present their project to a panel of investors specialized in their field
- Establish or consolidate links with these investors and obtain their qualitative feedback on their project
The Invest In Biomed program
6 group or individual workshops from March to June 2025, led by healthcare and fundraising experts
Flash review of your project
A 360° analysis of your project, based on a deck review and two interviews
Experts involved: Eurobiomed's experts
Understand investors' expectations and their modalities of investments
Experts involved: healthcare VCs
Work on your equity story and deck
Experts involved: healthcare fundraising experts
Refine your oral presentation
Experts involved: communications consultant
Health investment day
Pitch presentations by project leaders and investors
BtoB networking session
Preparing the next steps of your fundraising
Investor meetings' debriefs
Preparation of next steps in the fundraising process
Experts involved: Eurobiomed's experts
Read the testimonials of 4 startups supported by Invest In Biomed
A look back at 2024
Class of 2024 healthcare fundraising experts
- Sofia ARNAL - Associate AdBio Partners, trained pharmacist
- Sophie BRAUN - Health consultant In Extenso Croissance
- Karine CHORRO - Phost'In Therapeutics, CEO and co-founder, ex deputy director Genepep
- Stéphane DEBONO - Former Deputy CEO and VP HalioDx
- Vincent FERT - Partner Turenne Groupe, former CEO/President HalioDx
- Pierre HORNUS - CEO/Co-founder Semeia
- Francine LANCELEUR BRENNING - Qualitalents Director, former General Manager/BD MediHandTrace
- Laure Hélène MERCIER - LH Mercier Conseil, consultant in fund raising, IPO, ex CFO Innate Pharma
- Claire NAUSSAC - Operating partner Truffle Capital
- Claire VERSCHELDE - ICOSA, Co-founding partner, IP specialist
- Grégory VOISIN - CEO and founder of ToxiPlan